Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ASKG-915 by AskGene Pharma for Transitional Cell Cancer (Urothelial Cell Cancer): Likelihood of Approval
ASKG-915 is under clinical development by AskGene Pharma and currently in Phase I for Transitional Cell Cancer (Urothelial Cell Cancer)....